Alternative dimerisation reagents for synthesis of iodixanol
Granted 13 Apr 2010 · no office action yet
Current assignee: GE Healthcare Bio Sciences · originally General Electric
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Arne Berg, Per Strande, Trygve Gulbrandsen, Harald Dugstad +1 · Examiner: Shailendra Kumar · AU 1621 · TC 1600
Life of the application
6 dated eventsAbstract
This invention relates generally to non-ionic X-ray contrast agents. It further relates to the synthesis of iodixanol. In particular, it relates to alternative dimerisation reagents in the conversion of 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (“Compound A†) to iodixanol.
Description
9 parts›CROSS REFERENCE TO RELATED APPLICATIONS
The present application claims benefit of priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 61/227,099 filed Jul. 21, 2009, the entire disclosure of which is hereby incorporated by reference.
›TECHNICAL FIELD
This invention relates generally to non-ionic X-ray contrast agents. It further relates to the synthesis of iodixanol. In particular, it relates to alternative dimerisation reagents in the conversion of 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (“Compound A”) to iodixanol.
›BACKGROUND OF THE INVENTION
Iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis(2,3-dihydroxypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hydroxypropane) is a non-ionic X-ray contrasting agent produced in large quantities by GE Healthcare in Lindesnes, Norway. The traditional industrial synthesis of iodixanol involves dimerisation of intermediate 5-acetamido-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (“Compound A”) as the final synthetic step. See Scheme 1 and U.S. Pat. No. 6,974,882.
Currently, the only dimerisation agent used in an industrial production of iodixanol is epichlorohydrin, shown below.
It is thus desirable to develop alternative dimerisation reagents that are suitable for conversion of Compound A to iodixanol with acceptable yield.
›SUMMARY OF THE INVENTION
The present invention provides a process for preparing iodixanol by dimerisation of Compound A using 1,3-dichloropropanol, 1,3-dibromopropanol, 1,3-diiodopropanol, THP protected 1,3-dichloropropanol (THP being tetrahydropyrane), THP protected 1,3-dibromopropanol, THP protected 1,3-diiodo propanol, acetoxy protected 1,3-dichloropropanol (acetoxy being COCH 3 ), acetoxy protected 1,3-dibromopropanol, acetoxy protected 1,3-diiodopropanol, MOM protected 1,3-dichloropropanol (MOM being CH 2 OCH 3 ), MOM protected 1,3-dibromopropanol, MOM protected 1,3-diiodopropanol, or dichloroacetone as the dimerisation agent. The instant dimerisation reaction is performed under alkaline conditions with pH values between about 10 and about 12.
›DETAILED DESCRIPTION OF THE INVENTION
The dimerisation reaction time of the present invention may vary from a few hours to several days. The dimerisation may proceed to full or partial conversion. Typical reaction temperatures may range from about 5° C. to about 50° C., preferably between about 10 and about 25° C. In addition, a lower reaction temperature may be preferred when selectivity (the ratio of iodixanol and impurities such as trimers and O-alkylated compounds) is desired.
The invention is illustrated further by the following examples that are not to be construed as limiting the invention in scope to the specific procedures or products described in them.
›Examples3
›Example 1
Acetoxy Protected 1,3-dibromopropanol
The sodium salt of Compound A was dissolved in dry DMAc at room temperature before 1,3-dibromo-2-acetoxypropane was added at the same temperature. A slow pH change was observed from 11.9 to 10.4. After 16 hours anhydrous K 2 CO 3 was added and the reaction was continued for an additional time before being worked up in the usual manner.
The calcium salt of Compound A was prepared in situ and after addition of 1,3-dibromo-2-acetoxypropane the reaction was carried out at 50° C.
›Example 2
THP Protected 1,3-dichloropropanol
Compound A (12.5 g, 16.7 mmol) was dissolved in DMAc (38 ml), and NaH (0.5 g, 1.1 eq) was added over a period of 15 min. Following the addition, the mixture was stirred at room temperature for 15 min before THP protected 1,3-dichloropropanol was added and the temperature raised to 80° C. NaI (0.25 g, 0.1 eq) was added after 3 days. About 35% conversion of Compound A was obtained after 6 days.
›Example 3
1,3-dichloropropanol
Compound A is dissolved in 2-methoxyethanol (0.8-1.2 mL/g Compound A) in the presence of NaOH. pH is adjusted to about 11.8-12.0 with hydrochloric acid, and 1,3-dichloropropanol (about 0.33 eq) is added. The reaction is conducted at 15° C. for about 40 hours. A conversion of about 55% of the starting material Compound A to iodixanol is observed, with only 1-2% of byproducts formed.
All patents, journal articles, publications and other documents discussed and/or cited above are hereby incorporated by reference.
Claims as granted
3 claimsLog in to read the claims of this application.
Log in to unlockClassifications
4 codes- C07C233/65
- C07C233/05
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock